Stay updated on ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Sign up to get notified when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record content is visible, including its design, eligibility criteria, outcomes, locations, publication, and data-sharing information.
    Difference
    92%
    Check dated 2026-11-07T11:38:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T11:29:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to transition updates. The clinical trial record itself remains unavailable.
    Difference
    1%
    Check dated 2026-10-24T11:37:15.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T12:50:22.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T13:18:34.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the typical study record content. This prevents users from viewing the study details and suggests an access restriction or site issue.
    Difference
    19%
    Check dated 2026-09-19T20:29:20.000Z thumbnail image

Stay in the know with updates to ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABT-165 Combo vs Bevacizumab Combo in Metastatic CRC Clinical Trial page.